Researchers at the Bauru School of Dentistry, University of São Paulo, have developed a novel artificial saliva using a sugarcane protein known as CANECPI-5, which shows promise in protecting teeth from acid damage and decay. This breakthrough addresses a critical need for patients with head and neck cancer, who often suffer from reduced saliva production due to radiotherapy. The artificial saliva functions by binding directly to tooth enamel, forming a protective barrier against harmful acids from food and beverages, and has demonstrated enhanced efficacy when combined with fluoride and xylitol.

The significance of this development lies in its potential to mitigate xerostomia (dry mouth) and its associated complications, particularly in cancer patients. Saliva plays a crucial role in maintaining oral health by controlling bacterial growth and preventing tooth demineralization. In vitro tests indicate that CANECPI-5 not only reduces bacterial activity but also slows the demineralization process, making it a valuable candidate for therapeutic applications. This innovation could transform the current dental care landscape for individuals experiencing severe oral health challenges post-cancer treatment, where no dedicated products exist.

The implications for future research and clinical practice are substantial. The patented CANECPI-5 protein opens avenues for the development of various delivery methods, including mouthwash, gel, and orodispersible films, which could enhance patient compliance and ease of use. Ongoing investigations aim to explore synergistic effects with other compounds, such as peptides from saliva, to further enhance its protective capabilities. This research not only shifts the paradigm in managing post-radiation oral health but also paves the way for new therapeutic strategies targeting periodontal disease and tissue repair, potentially expanding the utility of CANECPI-5 beyond dental applications.

Source: sciencedaily.com